Nocturnal Vestibular Immunotherapy (NVI) shows Superior and Faster Protocol Compliance When Compared to Subcutaneous immunotherapy (SCIT) in a cohort of patients in the USA

View at publisher
Authors: Roberto Garcia-Ibanez, LUIS Cekan, Ernrique Fernández-Caldas
Cited by: 0

Fields of Study & Subjects

Allergic Rhinitis and Sensitization Food Allergy and Anaphylaxis Research Asthma and respiratory diseases

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB168–AB168
Publication date
1 February 2026
Language
EN